Sinovac’s COVID Vaccine for Coronavirus Receives Approval in China
- 3 years ago
COVID-19 Vaccine update: Chinese regulator National Medical Products Administration (NMPA) has granted approval to Sinovac Biotech’s unit for its Covid-19 vaccine.
Following the approval granted to the company’s Beijing-based unit Sinovac Life Sciences, the vaccine is now available for use on the general public.
With this development, Sinovac’s vaccine became the second one to receive approval in China, Reuters reported.
Last December, a vaccine developed by the Beijing institute and state-owned China National Pharmaceutical Group (Sinopharm) received approval.
Currently, both the vaccines, as well as a third vaccine candidate from Sinopharm, are in use in the vaccination programme in the country, which has administered more than 31 million doses, focusing mainly on people at higher infection risk.
This article was originally published by Pharceutical Technology on February 8, 2021:
https://bit.ly/3b1t8S0
FIND the model and photographer created this video on Pexels:
https://bit.ly/3aqnKYj
SUBSCRIBE to our channel:
http://bit.ly/3pOwYUZ
Following the approval granted to the company’s Beijing-based unit Sinovac Life Sciences, the vaccine is now available for use on the general public.
With this development, Sinovac’s vaccine became the second one to receive approval in China, Reuters reported.
Last December, a vaccine developed by the Beijing institute and state-owned China National Pharmaceutical Group (Sinopharm) received approval.
Currently, both the vaccines, as well as a third vaccine candidate from Sinopharm, are in use in the vaccination programme in the country, which has administered more than 31 million doses, focusing mainly on people at higher infection risk.
This article was originally published by Pharceutical Technology on February 8, 2021:
https://bit.ly/3b1t8S0
FIND the model and photographer created this video on Pexels:
https://bit.ly/3aqnKYj
SUBSCRIBE to our channel:
http://bit.ly/3pOwYUZ